Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1986 1
1987 1
1990 1
1991 1
1992 2
1994 1
1996 1
1997 3
2000 2
2002 2
2003 2
2004 2
2006 1
2007 1
2008 1
2009 2
2011 3
2012 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
Pfreundschuh M, Kuhnt E, Trümper L, Osterborg A, Trneny M, Shepherd L, Gill DS, Walewski J, Pettengell R, Jaeger U, Zinzani PL, Shpilberg O, Kvaloy S, de Nully Brown P, Stahel R, Milpied N, López-Guillermo A, Poeschel V, Grass S, Loeffler M, Murawski N; MabThera International Trial (MInT) Group. Pfreundschuh M, et al. Lancet Oncol. 2011 Oct;12(11):1013-22. doi: 10.1016/S1470-2045(11)70235-2. Epub 2011 Sep 21. Lancet Oncol. 2011. PMID: 21940214 Clinical Trial.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, Knapper S, Batten LM, Canham J, Hinson EL, Betteridge S, Overgaard UM, Gilkes A, Potter N, Mehta P, Kottaridis P, Cavenagh J, Hemmaway C, Arnold C, Freeman SD, Dennis M; PORTEC Study Group. Russell NH, et al. J Clin Oncol. 2024 Apr 1;42(10):1158-1168. doi: 10.1200/JCO.23.00943. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215358 Clinical Trial.
Leukaemia inhibitory factor and bone cell function.
Martin TJ, Allan EH, Evely RS, Reid IR. Martin TJ, et al. Among authors: evely rs. Ciba Found Symp. 1992;167:141-50; discussion 150-5. doi: 10.1002/9780470514269.ch9. Ciba Found Symp. 1992. PMID: 1425010 Review.
Severe cholestasis associated with stanozolol.
Evely RS, Triger DR, Milnes JP, Low-Beer TS, Williams R. Evely RS, et al. Br Med J (Clin Res Ed). 1987 Mar 7;294(6572):612-3. doi: 10.1136/bmj.294.6572.612-a. Br Med J (Clin Res Ed). 1987. PMID: 3103828 Free PMC article. No abstract available.
Asymptomatic osteomyelitis of the symphysis pubis.
Evans TW, Evely RS, Morcos SK. Evans TW, et al. Among authors: evely rs. Postgrad Med J. 1985 Mar;61(713):267-8. doi: 10.1136/pgmj.61.713.267. Postgrad Med J. 1985. PMID: 3983066 Free PMC article.
Characterization of acute lymphoblastic leukemia progenitor cells.
Cox CV, Evely RS, Oakhill A, Pamphilon DH, Goulden NJ, Blair A. Cox CV, et al. Among authors: evely rs. Blood. 2004 Nov 1;104(9):2919-25. doi: 10.1182/blood-2004-03-0901. Epub 2004 Jul 8. Blood. 2004. PMID: 15242869 Free article.
29 results